Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves' disease. Issue 2 (16th October 2019)

• Record Type: Journal Article
• Authors: Gargouri, Bochra; Mseddi, Malek; Mnif, Fatma; Abid, Mohamed; Attia, Hamadi; Lassoued, Saloua
• Is Part Of: Journal of clinical laboratory analysis. Volume 34:Issue 2(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-10-16
• Subjects: autoantibody -- catalase -- Graves' disease -- hydrogen peroxide -- malondialdehyde -- oxidative stress; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.23051
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract: Background: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme in patients with Graves' disease (GD) and healthy controls in a comparative way. Methods: The CAT activity was evaluated via spectrophotometric method. Using enzyme‐linked immunosorbent assay, the reactivities of autoantibody toward native, malondialdehyde (MDA) and hydrogen peroxide (H2 O2 ) modified CAT were evaluated in plasmas of patients and controls. Results: Reduced CAT activity was found in patients compared with controls ( P < .05). It was proved that levels of IgG antibodies against MDA‐modified CAT were higher than against unmodified ones ( P < .001). No changes were found for the reactivities to H2 O2 ‐modified CAT. Positive correlation was found between the reactivity to MDA‐modified CAT and the triiodothyronine level ( P < .001, r = .6). Conclusion: Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology.